APA (7th ed.) Citation

Dou, D., Ge, X., Wang, X., Xu, X., Zhang, Z., Seng, J., . . . Han, M. (2019). EZH2 Contributes To Cisplatin Resistance In Breast Cancer By Epigenetically Suppressing miR-381 Expression. OncoTargets & Therapy, 12, 9627. https://doi.org/10.2147/OTT.S214104

Chicago Style (17th ed.) Citation

Dou, Dongwei, Xin Ge, Xinxing Wang, Xiaodong Xu, Zhe Zhang, Jingjing Seng, Zhang Cao, Yuanting Gu, and Mingli Han. "EZH2 Contributes To Cisplatin Resistance In Breast Cancer By Epigenetically Suppressing MiR-381 Expression." OncoTargets & Therapy 12 (2019): 9627. https://doi.org/10.2147/OTT.S214104.

MLA (9th ed.) Citation

Dou, Dongwei, et al. "EZH2 Contributes To Cisplatin Resistance In Breast Cancer By Epigenetically Suppressing MiR-381 Expression." OncoTargets & Therapy, vol. 12, 2019, p. 9627, https://doi.org/10.2147/OTT.S214104.